Ascendis Pharma A/S Research and Development Expense
Ascendis Pharma A/S (ASND) reported Research and Development Expense of EUR 303.62 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-11.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ResearchAndDevelopmentExpense · last filed 2026-02-11
- Ascendis Pharma A/S research and development expense for the quarter ending 2025-12-31 was 78.15M EUR, a 1.44% decline year-over-year.
- Ascendis Pharma A/S research and development expense for the quarter ending 2025-09-30 was 66.88M EUR, a 9.06% decline year-over-year.
- Ascendis Pharma A/S research and development expense for the quarter ending 2025-06-30 was 71.99M EUR, a 13.76% decline year-over-year.
- Ascendis Pharma A/S research and development expense for the quarter ending 2025-03-31 was 86.60M EUR, a 22.52% increase year-over-year.
| Period end | Research And Development Expense 3 month | Research And Development Expense 6 month | Research And Development Expense 9 month | Research And Development Expense 12 month |
|---|---|---|---|---|
| 2025-12-31 | 78.15M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11 | 145.03M EUR derived: sum of 2 quarters · filed 2026-02-11 | 217.02M EUR derived: sum of 3 quarters · filed 2026-02-11 | 303.62M EUR 20-F · filed 2026-02-11 |
| 2025-09-30 | 66.88M EUR 6-K · filed 2025-11-12 | 138.87M EUR derived: sum of 2 quarters · filed 2025-11-12 | 225.47M EUR 6-K · filed 2025-11-12 | 304.77M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2025-06-30 | 71.99M EUR 6-K · filed 2025-08-07 | 158.59M EUR 6-K · filed 2025-08-07 | 237.89M EUR derived: sum of 3 quarters · filed 2026-02-11 | 311.43M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2025-03-31 | 86.60M EUR 6-K · filed 2025-05-01 | 165.90M EUR derived: sum of 2 quarters · filed 2026-02-11 | 239.44M EUR derived: sum of 3 quarters · filed 2026-02-11 | 322.92M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-12-31 | 79.30M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11 | 152.84M EUR derived: sum of 2 quarters · filed 2026-02-11 | 236.32M EUR derived: sum of 3 quarters · filed 2026-02-11 | 307.00M EUR 20-F · filed 2026-02-11 |
| 2024-09-30 | 73.54M EUR 6-K · filed 2025-11-12 | 157.02M EUR derived: sum of 2 quarters · filed 2025-11-12 | 227.71M EUR 6-K · filed 2025-11-12 | 318.59M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-06-30 | 83.48M EUR 6-K · filed 2025-08-07 | 154.16M EUR 6-K · filed 2025-08-07 | 245.05M EUR derived: sum of 3 quarters · filed 2026-02-11 | 356.49M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-03-31 | 70.69M EUR 6-K · filed 2025-05-01 | 161.57M EUR derived: sum of 2 quarters · filed 2026-02-11 | 273.01M EUR derived: sum of 3 quarters · filed 2026-02-11 | 378.03M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2023-12-31 | 90.88M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11 | 202.32M EUR derived: sum of 2 quarters · filed 2026-02-11 | 307.34M EUR derived: sum of 3 quarters · filed 2026-02-11 | 413.45M EUR 20-F · filed 2026-02-11 |
| 2023-09-30 | 111.44M EUR 6-K · filed 2024-11-14 | 216.46M EUR derived: sum of 2 quarters · filed 2024-11-14 | 322.57M EUR 6-K · filed 2024-11-14 | 431.19M EUR derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-06-30 | 105.02M EUR 6-K · filed 2024-09-03 | 211.13M EUR 6-K · filed 2024-09-03 | 319.75M EUR derived: sum of 3 quarters · filed 2025-02-12 | 417.18M EUR derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-03-31 | 106.11M EUR 6-K · filed 2024-05-02 | 214.73M EUR derived: sum of 2 quarters · filed 2025-02-12 | 312.16M EUR derived: sum of 3 quarters · filed 2025-02-12 | 402.55M EUR derived: sum of 4 quarters · filed 2025-02-12 |
| 2022-12-31 | 108.62M EUR derived: 20-F 12 month − 6-K 9 month · filed 2025-02-12 | 206.05M EUR derived: sum of 2 quarters · filed 2025-02-12 | 296.43M EUR derived: sum of 3 quarters · filed 2025-02-12 | 379.62M EUR 20-F · filed 2025-02-12 |
| 2022-09-30 | 97.43M EUR 6-K · filed 2023-11-07 | 187.81M EUR derived: sum of 2 quarters · filed 2023-11-07 | 271.01M EUR 6-K · filed 2023-11-07 | 336.66M EUR derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-06-30 | 90.38M EUR 6-K · filed 2023-09-05 | 173.58M EUR 6-K · filed 2023-09-05 | 239.23M EUR derived: sum of 3 quarters · filed 2024-02-07 | 297.99M EUR derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-03-31 | 83.19M EUR 6-K · filed 2023-04-27 | 148.84M EUR derived: sum of 2 quarters · filed 2024-02-07 | 207.60M EUR derived: sum of 3 quarters · filed 2024-02-07 | 290.91M EUR derived: sum of 4 quarters · filed 2024-02-07 |
| 2021-12-31 | 65.65M EUR derived: 20-F 12 month − 6-K 9 month · filed 2024-02-07 | 124.41M EUR derived: sum of 2 quarters · filed 2024-02-07 | 207.72M EUR derived: sum of 3 quarters · filed 2024-02-07 | 295.87M EUR 20-F · filed 2024-02-07 |
| 2021-09-30 | 58.76M EUR 6-K · filed 2022-11-02 | 142.07M EUR derived: sum of 2 quarters · filed 2022-11-02 | 230.22M EUR 6-K · filed 2022-11-02 | 305.97M EUR derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | 83.31M EUR 6-K · filed 2022-08-10 | 171.46M EUR 6-K · filed 2022-08-10 | 247.21M EUR derived: sum of 3 quarters · filed 2023-02-16 | 311.27M EUR derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | 88.15M EUR 6-K · filed 2022-05-11 | 163.90M EUR derived: sum of 2 quarters · filed 2023-02-16 | 227.96M EUR derived: sum of 3 quarters · filed 2023-02-16 | 291.54M EUR derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | 75.75M EUR derived: 20-F 12 month − 6-K 9 month · filed 2023-02-16 | 139.81M EUR derived: sum of 2 quarters · filed 2023-02-16 | 203.39M EUR derived: sum of 3 quarters · filed 2023-02-16 | 260.90M EUR 20-F · filed 2023-02-16 |
| 2020-09-30 | 64.06M EUR 6-K · filed 2021-11-10 | 127.64M EUR derived: sum of 2 quarters · filed 2021-11-10 | 185.15M EUR 6-K · filed 2021-11-10 | 235.43M EUR derived: sum of 4 quarters · filed 2022-03-02 |
| 2020-06-30 | 63.58M EUR 6-K · filed 2021-08-27 | 121.09M EUR 6-K · filed 2021-08-27 | 171.37M EUR derived: sum of 3 quarters · filed 2022-03-02 | 217.63M EUR derived: sum of 4 quarters · filed 2022-03-02 |
| 2020-03-31 | 57.52M EUR 6-K · filed 2021-05-27 | 107.79M EUR derived: sum of 2 quarters · filed 2022-03-02 | 154.05M EUR derived: sum of 3 quarters · filed 2022-03-02 | 197.88M EUR derived: sum of 4 quarters · filed 2022-03-02 |
| 2019-12-31 | 50.28M EUR derived: 20-F 12 month − 6-K 9 month · filed 2022-03-02 | 96.54M EUR derived: sum of 2 quarters · filed 2022-03-02 | 140.36M EUR derived: sum of 3 quarters · filed 2022-03-02 | 191.62M EUR 20-F · filed 2022-03-02 |
| 2019-09-30 | 46.26M EUR 6-K · filed 2020-11-12 | 90.08M EUR derived: sum of 2 quarters · filed 2020-11-12 | 141.34M EUR 6-K · filed 2020-11-12 | 179.34M EUR derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-06-30 | 43.83M EUR 6-K · filed 2020-08-27 | 95.08M EUR 6-K · filed 2020-08-27 | 133.08M EUR derived: sum of 3 quarters · filed 2021-03-10 | 164.59M EUR derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-03-31 | 51.26M EUR 6-K · filed 2020-05-19 | 89.25M EUR derived: sum of 2 quarters · filed 2021-03-10 | 120.77M EUR derived: sum of 3 quarters · filed 2021-03-10 | 161.00M EUR derived: sum of 4 quarters · filed 2021-03-10 |
| 2018-12-31 | 37.99M EUR derived: 20-F 12 month − 6-K 9 month · filed 2021-03-10 | 69.51M EUR derived: sum of 2 quarters · filed 2021-03-10 | 109.74M EUR derived: sum of 3 quarters · filed 2021-03-10 | 140.28M EUR 20-F · filed 2021-03-10 |
| 2018-09-30 | 31.51M EUR 6-K · filed 2019-11-18 | 71.75M EUR derived: sum of 2 quarters · filed 2019-11-18 | 102.29M EUR 6-K · filed 2019-11-18 | 130.32M EUR derived: sum of 4 quarters · filed 2020-04-03 |
| 2018-06-30 | 40.23M EUR 6-K · filed 2019-08-28 | 70.78M EUR 6-K · filed 2019-08-28 | 98.81M EUR derived: sum of 3 quarters · filed 2020-04-03 | 127.88M EUR derived: sum of 4 quarters · filed 2020-04-03 |
| 2018-03-31 | 30.54M EUR 6-K · filed 2019-05-30 | 58.57M EUR derived: sum of 2 quarters · filed 2020-04-03 | 87.64M EUR derived: sum of 3 quarters · filed 2020-04-03 | 109.52M EUR derived: sum of 4 quarters · filed 2020-04-03 |
| 2017-12-31 | 28.03M EUR derived: 20-F 12 month − 6-K 9 month · filed 2020-04-03 | 57.10M EUR derived: sum of 2 quarters · filed 2020-04-03 | 78.98M EUR derived: sum of 3 quarters · filed 2020-04-03 | 99.59M EUR 20-F · filed 2020-04-03 |
| 2017-09-30 | 29.07M EUR 6-K · filed 2018-11-28 | 50.95M EUR derived: sum of 2 quarters · filed 2018-11-28 | 71.56M EUR 6-K · filed 2018-11-28 | |
| 2017-06-30 | 21.88M EUR 6-K · filed 2018-08-29 | 42.49M EUR 6-K · filed 2018-08-29 | ||
| 2017-03-31 | 20.61M EUR 6-K · filed 2018-05-30 | |||
| 2016-12-31 | 66.02M EUR 20-F · filed 2019-04-03 | |||
| 2015-12-31 | 40.53M EUR 20-F · filed 2018-03-28 |